Massmutual Trust CO Fsb Biotechnology

Massmutual Trust CO Fsb

$3.7 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
REPL Replimune Group, Inc.	$556M	$2,000 0.0% of portfolio	295	Q2 2024 Added 478.43%
TRVI Trevi Therapeutics, Inc.	$343M	$2,000 0.0% of portfolio	528	Q2 2025 New
VCEL Vericel Corp	$1.71B	$2,000 0.0% of portfolio	51	Q1 2025 Reduced 3.77%
WVE Wave Life Sciences Ltd.	$601M	$2,000 0.0% of portfolio	339	Q2 2025 Reduced 11.95%
XNCR Xencor Inc	$541M	$2,000 0.0% of portfolio	319	Q2 2025 Added 206.73%
XERS Xeris Biopharma Holdings, Inc.	$636M	$2,000 0.0% of portfolio	554	Q2 2025 Added 31.9%
ACAD Acadia Pharmaceuticals Inc	$3.65B	$1,000 0.0% of portfolio	62	Q2 2025 New
FOLD Amicus Therapeutics, Inc.	$1.76B	$1,000 0.0% of portfolio	228	Q2 2025 Reduced 63.98%
APLS Apellis Pharmaceuticals, Inc.	$2.2B	$1,000 0.0% of portfolio	106	Q2 2025 New
BBIO Bridge Bio Pharma, Inc.	$6.93B	$1,000 0.0% of portfolio	33	Q2 2025 Reduced 23.26%
DNLI Denali Therapeutics Inc.	$1.95B	$1,000 0.0% of portfolio	123	Q2 2025 Reduced 16.89%
HUMA Humacyte, Inc.	$249M	$1,000 0.0% of portfolio	765	Q2 2025 New
NUVB Nuvation Bio Inc.	$452M	$1,000 0.0% of portfolio	970	Q2 2025 Added 21.1%
RCKT Rocket Pharmaceuticals, Inc.	$253M	$1,000 0.0% of portfolio	442	Q2 2025 Reduced 36.59%
SWTX Spring Works Therapeutics, Inc.	$2.93B	$1,000 0.0% of portfolio	27	Q2 2025 Reduced 82.8%
KMPH Kempharm, Inc	$170M	$1,000 0.0% of portfolio	255	Q2 2025 Added 70.0%
ARAV Aravive, Inc.	$0	$0 0.0% of portfolio	9,300	Q3 2021 New
BCRX Biocryst Pharmaceuticals Inc	$1.62B	$0 0.0% of portfolio	58	Q2 2025 New
COGT Cogent Biosciences, Inc.	$615M	$0 0.0% of portfolio	29	Q2 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$477M	$0 0.0% of portfolio	51	Q2 2025 New
DSGN Design Therapeutics, Inc.	$198M	$0 0.0% of portfolio	239	Q1 2024 New
IMVT Immunovant, Inc.	$3.55B	$0 0.0% of portfolio	9	Q2 2025 Reduced 94.64%
NTLA Intellia Therapeutics, Inc.	$899M	$0 0.0% of portfolio	99	Q2 2025 Reduced 27.21%
KURA Kura Oncology, Inc.	$441M	$0 0.0% of portfolio	62	Q2 2025 Reduced 70.62%
NUVL Nuvalent, Inc.	$3.35B	$0 0.0% of portfolio	4	Q2 2025 New
SNDX Syndax Pharmaceuticals Inc	$547M	$0 0.0% of portfolio	71	Q2 2025 Added 54.35%
TBPH Theravance Biopharma, Inc.	$755M	$0 0.0% of portfolio	33	Q2 2025 New
VCYT Veracyte, Inc.	$1.73B	$0 0.0% of portfolio	13	Q2 2025 Reduced 77.59%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.